Sanofi Consumer Healthcare India Limited (NSEI: SANOFICONR)
Health Care · Pharmaceuticals · IN
Rs3,722.90
-0.36% today · -21.3% 1Y
Sanofi Consumer Healthcare India Limited (NSEI: SANOFICONR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $886.34M and employs 597 people.
Over the last twelve months the share price has lost 21.3%, trading between 3.69K and 5.25K.
Tweenvest scores Sanofi Consumer Healthcare India Limited across four factors: quality 90/100, value 78/100, dividend 32/100. Its strongest factor is quality.
SANOFICONR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $886.34M
- Revenue (TTM)
- $100.45M
- P/E
- 32.24
- EPS
- 115.49
- Dividend yield
- 2.01%
- Beta (5Y)
- 0.27
- 52-week high
- Rs5,255.00
- 52-week low
- Rs3,691.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.03M
- Employees
- 597
- Next earnings
- —
About Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited, an Indian company founded in 2023 and based in Mumbai, specializes in fast-moving consumer healthcare products. The firm's offerings cover categories such as allergy relief, overall well-being, and pain management, featuring prominent brands like Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU. These products are distributed through a comprehensive network that includes distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. The company operates as a subsidiary of Opella Healthcare Participations B.V.
- ISIN
- INE0UOS01011
- Founded
- 2023
- Listed since
- Sep 13, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Soho Global Health TbkIDX: SOHO | $904.16M | Rp1,275.00 | -7.94% |
| Procter & Gamble Health LimitedBSE: 500126 | $897.79M | Rs5,232.00 | -1.32% |
| MedinCell S.A.ENXTPA: MEDCL | $897.28M | €26.28 | +18.38% |
| Hainan Haiyao Co., Ltd.SZSE: 000566 | $893.56M | CN¥4.62 | -1.49% |
| Mega Lifesciences Public Company LimitedSET: MEGA | $876.44M | ฿33.75 | -2.88% |
| Alumis Inc.NasdaqGS: ALMS | $876.28M | $6.77 | -2.31% |
| Chongqing Lummy Pharmaceutical Co., Ltd.SZSE: 300006 | $875.23M | CN¥5.56 | +2.02% |
| Wuhan Keqian Biology Co.,LtdSHSE: 688526 | $853.44M | CN¥12.34 | +1.31% |
Figures last refreshed Oct 4, 2026.